Prevail Global Study

Recruiting now · Not applicable

Conditions studied: Coronary Artery Disease

In brief

The purpose of the study is to evaluate the clinical safety and efficacy of the Prevail DCB.

Key facts

Study ID
NCT06535854
Run by
Medtronic Vascular
People needed
1205
Starts
2025-02-24
Expected to finish
2031-02-01
Last updated by the study team
2026-04-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.